BPG is committed to discovery and dissemination of knowledge
Article Citation
Wang XW, Tang YX, Li FX, Wang JL, Yao GP, Zeng DT, Tang YL, Chi BT, Su QY, Huang LQ, Qin DY, Chen G, Feng ZB, He RQ. Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(10): 4244-4263 [PMID: 39473957 DOI: 10.4251/wjgo.v16.i10.4244]
Please LOGIN to submit a new comment.
Write to the Help Desk